Company / Free Cash Flow
Maze Therapeutics, Inc. Free Cash Flow History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$112.7M
FY2025
5-year range
-$112.7M / -$112.7M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#113 of 194
Health Care
What the data says
At -$113M, Maze Therapeutics, Inc.'s free cash flow ranks #113 of 194 in the Health Care sector.
Based on SEC 10-K filings.
-$113M in FY2025.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 194 in Health CareTop 58% of 194This company -$112.7M Sector average $470.6M
▼
-124.0% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$112.7M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026